Your session is about to expire
← Back to Search
Behavioral Intervention
iCanWork Intervention for Cancer Survivorship (iCanWork Trial)
N/A
Waitlist Available
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
diagnosed with cancer (all types) treated with curative intent and of working age (between 18 and 65 at the time of diagnosis)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months, 12 months, 18 months, 24 months
Awards & highlights
iCanWork Trial Summary
This trial will help to assess how well the iCanWork intervention helps cancer survivors return to work, and evaluate the impact on their quality of life, health service utilization, RTW readiness, time to RTW, and work capacity.
Who is the study for?
The iCanWork trial is for cancer survivors in Canada, aged 18-65, who were working at the time of diagnosis and are currently on sick leave or disability but haven't been off work for more than 2 years. Participants must understand English or French and have not yet started returning to work since their treatment.Check my eligibility
What is being tested?
This study tests the 'iCanWork' program's ability to help cancer survivors return to work. It looks at how well it improves quality of life, reduces healthcare use, prepares participants for work re-entry, speeds up return-to-work time, and enhances job capacity.See study design
What are the potential side effects?
Since 'iCanWork' is a non-medical intervention focusing on employment support rather than a drug or medical procedure, it does not have typical side effects. However, individual experiences may vary based on personal circumstances.
iCanWork Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I was diagnosed with cancer and aimed to cure it while I was between 18 and 65 years old.
iCanWork Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 months, 12 months, 18 months, 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months, 12 months, 18 months, 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from baseline return to work status in the course of the 24-month study
Secondary outcome measures
Change from baseline health related quality of life in the course of the 24-month study
Change from baseline readiness to return to work in the course of the 24-month study
Change from baseline work capacity in the course of the 24-month study
iCanWork Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: iCanWork InterventionExperimental Treatment1 Intervention
iCanWork includes 6 1-hour sessions with a VRC and 1 to 4 1-hour sessions with an OT. In the positive event that a participant has returned to work during the study, three of the six VRC sessions are reserved to support the participants in their transition to the workplace.
Group II: ControlActive Control1 Intervention
Participants randomized to the control group will receive their usual care and will be referred to the Cancer Work website for educational resources related to RTW. If they contact the team with RTW-related questions, they will be referred to their care teams.
Find a Location
Who is running the clinical trial?
McGill UniversityLead Sponsor
394 Previous Clinical Trials
998,111 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was diagnosed with cancer and aimed to cure it while I was between 18 and 65 years old.I was working or studying when I was diagnosed.I have been on sick leave or long-term disability for less than 2 years.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: iCanWork Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Might I be eligible to partake in this experiment?
"To be considered for this experiment, 270 individuals with malignant neoplasms should apply and must fall between 18-65 years of age."
Answered by AI
Would this trial accommodate elderly participants aged 85 or above?
"To be considered for this trial, applicants must fall between 18 to 65 years of age. For those younger than the minimum requirement, there are 46 clinical trials available and 257 studies cater to seniors above the maximum limit."
Answered by AI
Are more volunteers being sought for this clinical research?
"Clinicaltrials.gov indicates that this clinical trial, posted on April 1st 2023 and last edited September 22nd 2022, does not currently accept participants. However, there are 296 other medical studies presently recruiting for volunteers."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger